Vimarsana
Biggest News Aggregation in the World

Page 4 - Spring Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spring Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spring Inc Today - Breaking & Trending Today

Elevar Therapeutics Names Paul Friel Chief Commercial - Vimarsana News

Elevar Therapeutics Names Paul Friel Chief Commercial

SALT LAKE CITY, May 23, 2022 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment...

Elevar Therapeutics Names Paul Friel Chief Commercial Officer, Michael Palucki VP of Manufacturing - Vimarsana News

Elevar Therapeutics Names Paul Friel Chief Commercial Officer, Michael Palucki VP of Manufacturing

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
BeyondSpring (NASDAQ:BYSI) and Processa Pharmaceuticals (NASDAQ:PCSA) Critical Survey - Vimarsana News

BeyondSpring (NASDAQ:BYSI) and Processa Pharmaceuticals (NASDAQ:PCSA) Critical Survey

BeyondSpring (NASDAQ:BYSI – Get Rating) and Processa Pharmaceuticals (NASDAQ:PCSA – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, earnings, risk, dividends and analyst recommendations. Valuation & Earnings This table compares BeyondSpring and Processa Pharmaceuticals’ […]

Reviewing IMARA (NASDAQ:IMRA) & BeyondSpring (NASDAQ:BYSI) - Vimarsana News

Reviewing IMARA (NASDAQ:IMRA) & BeyondSpring (NASDAQ:BYSI)

BeyondSpring (NASDAQ:BYSI – Get Rating) and IMARA (NASDAQ:IMRA – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, earnings, institutional ownership and dividends. Analyst Recommendations This is a breakdown of recent ratings and recommmendations […]

CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation - Vimarsana News

CARsgen Appoints Richard John Daly as the President of CARsgen Therapeutics Corporation

/PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company mainly focused on innovative CAR T-cell therapies for the treatment of...